Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma

Junchao Guo, Jörg Kleeff, Yupei Zhao, Junsheng Li, Thomas Giese, Irene Esposito, Markus W. Büchler, Murray Korc, Helmut Friess

Research output: Contribution to journalArticle

24 Scopus citations


Pancreatic ductal adenocarcinoma (PDAC) is characterized by multiple alterations in the TGF-β signaling pathway. Yes-associated protein (YAP65) interacts with Smad7 thereby influencing TGF-β signaling. In the present study, the expression of YAP65 in PDAC was analyzed in order to elucidate the potential role of this molecule in the pathogenesis of pancreatic cancer. YAP65 mRNA expression levels in human pancreatic tissue samples and cell lines were analyzed by Northern blotting and quantitative RT-PCR. Immunohistochemistry was carried out to localize and quantify YAP65 expression in relation to Smad7 expression and Smad4 mutations. The effects of TGF-β1 on Smad7 and YAP65 mRNA expression were analyzed by quantitative RT-PCR. Enhanced expression of YAP65 mRNA was identified by Northern blotting and quantitative RT-PCR in PDAC in comparison to the normal pancreas (2.5-fold increase) and to chronic pancreatitis (1.3-fold increase). In the normal pancreas, YAP65 was absent in acinar cells, large ducts and islet cells, but exhibited moderate to strong immunoreactivity in centroacinar cells and ductules. Tubular complexes in CP and CP-like lesions in PDAC also exhibited strong staining. In contrast, weak to moderate YAP65 immunoreactivity was present in the cancer cells. There was no correlation between YAP65 immunostaining and Smad7 staining or Smad4 mutations in the cancer samples. TGF-β1 strongly induced Smad7 mRNA in Colo-357 and in Panc-1 cells, but only slightly induced YAP65 mRNA in Colo-357 cells. In conclusion, YAP65 is expressed mainly in centroacinar and small ductal cells in the normal pancreas. In PDAC, YAP65 is present in tubular complexes and to a lesser extent in cancer cells. Together with the known function of YAP65 in different growth and differentiation regulating pathways, it is suggested that this gene plays a role in the normal and diseased pancreas.

Original languageEnglish (US)
Pages (from-to)761-767
Number of pages7
JournalInternational Journal of Molecular Medicine
Issue number5
StatePublished - May 1 2006


  • Centroacinar cells
  • Pancreatic cancer
  • Tubular complexes
  • YAP 65

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.

  • Cite this

    Guo, J., Kleeff, J., Zhao, Y., Li, J., Giese, T., Esposito, I., Büchler, M. W., Korc, M., & Friess, H. (2006). Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. International Journal of Molecular Medicine, 17(5), 761-767.